2933

antibody from Cell Signaling Technology, Inc

Targeting: BCL2L11 BIM, BimEL, BimL, BimS, BOD

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunoprecipitation (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

2933

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#2933, RRID:AB_1030947

Product name

Bim (C34C5) Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse, Rat

Host

Rabbit

Storage

-20°C

References

Submitted references

BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.

Faber AC, Corcoran RB, Ebi H, Sequist LV, Waltman BA, Chung E, Incio J, Digumarthy SR, Pollack SF, Song Y, Muzikansky A, Lifshits E, Roberge S, Coffman EJ, Benes CH, Gómez HL, Baselga J, Arteaga CL, Rivera MN, Dias-Santagata D, Jain RK, Engelman JA
Cancer discovery 2011 Sep;1(4):352-65

---

Bcl-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response.

Pritchard JR, Gilbert LA, Meacham CE, Ricks JL, Jiang H, Lauffenburger DA, Hemann MT
Cancer research 2011 Sep 1;71(17):5850-8

---

Escherichia coli subtilase cytotoxin induces apoptosis regulated by host Bcl-2 family proteins Bax/Bak.

May KL, Paton JC, Paton AW
Infection and immunity 2010 Nov;78(11):4691-6